Next-generation sequencing discriminates myelodysplastic/myeloproliferative neoplasms from paraneoplastic leukemoid reaction in cancer patients with hyperleukocytosis

Leuk Lymphoma. 2018 Jul;59(7):1742-1745. doi: 10.1080/10428194.2017.1397669. Epub 2017 Nov 8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Biomarkers, Tumor
  • Bone Marrow / pathology
  • DNA Mutational Analysis
  • Diagnosis, Differential
  • Gene Expression Profiling
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Leukemoid Reaction / diagnosis*
  • Leukemoid Reaction / genetics*
  • Leukemoid Reaction / mortality
  • Leukocytosis / genetics*
  • Leukocytosis / pathology*
  • Mutation
  • Myelodysplastic Syndromes / diagnosis*
  • Myelodysplastic Syndromes / genetics*
  • Myelodysplastic Syndromes / mortality
  • Myeloproliferative Disorders / diagnosis*
  • Myeloproliferative Disorders / genetics*
  • Myeloproliferative Disorders / mortality
  • Prognosis

Substances

  • Biomarkers, Tumor